The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease that can cause muscle weakness, fatigue and problems ...

The program is specifically designed to remove critical barriers to proper nutrition while helping myasthenia patients improve their daily quality of life, treatment adherence, and overall health.

Get Autoimmune disease latest news, Article video and Photos on Autoimmune disease Explore latest health updates, news, information from TheHealthSite.com ...

Myasthenia gravis (MG) is a chronic autoimmune condition that disrupts communication between nerves and muscles, leading to weakness that can fluctuate throughout the day. Symptoms often worsen with ...

Myasthenia gravis (MG) is a chronic autoimmune neuromuscular condition that causes muscle weakness and severe fatigue. The fatigue associated with MG is often described as fatigable weakness, meaning ...

Already on a roll with its first-in-class FcRn blocker Vyvgart, argenx has reported successful trial results that could pave the way for the fast-rising blockbuster to reach a new indication—ocular ...

NEW YORK CITY, New York — Monica Seles, the nine-time Grand Slam champion and International Tennis Hall of Famer, is offering one of her most comprehensive updates yet on how she has been navigating ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. An mRNA‑based CAR T therapy called Descartes‑08 is giving many people with myasthenia gravis ...